An illustration of a heart with an Impella CP with SmartAssist in the left ventricular on a blue background with a light blue hash pattern on the right side.

RCT Proves Higher Survival With Impella in Cardiogenic Shock

The DanGer Shock RCT Found That Routine Use of Impella CP® Reduces All-Cause Mortality at 180 Days in AMI Cardiogenic Shock Due to STEMI Compared to Standard Care¹

Learn More

DanGer Shock Results from Dr. Jacob Møller at ACC 2024

Jacob Møller, MD, the principal investigator of the DanGer Shock trial, discusses study results he presented at ACC 2024.

Learn More Watch Interview

Sign up for Latest HeartRecovery Updates

The Heart of the Matter: Best Practice Approach on High-Risk Percutaneous Coronary Intervention

“The Heart of the Matter: Best practice approach on high-risk percutaneous coronary intervention” is a publication of eight articles addressing patient management and mechanical circulatory support (MCS) related to protected, high-risk percutaneous coronary intervention (PCI).

Learn More

Protected PCI

Learn more about protected PCI.

Learn More

Surgical Applications

Learn more about surgical applications for Impella® heart pumps.

Learn More

Young nurse smiling and other nurses standing behind her.

AMI Cardiogenic Shock

Learn more about Impella® heart pumps and cardiogenic shock.

Learn More

Young doctor standing in front and smiling. Group of doctors sitting in background and discussing.

Right-sided Heart Failure

Learn more about Impella® RP and right-sided heart failure.

Learn More

Native Heart and Lung Recovery

Conditions & Therapies

Access education, clinical evidence and practice support for Protected PCI, AMI cardiogenic shock, right heart failure, surgical applications and severe lung failure.

Learn More